⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12425172 | 1.00 | — | — | |
| SCHEMBL19243853 | 0.77 | — | — | |
| SCHEMBL11280612 | 0.77 | — | — | |
| SCHEMBL13522211 | 0.75 | — | — | |
| SCHEMBL12640776 | 0.71 | INMT (0.44) | — | |
| SCHEMBL29640103 | 0.71 | — | — | |
| SCHEMBL14191803 | 0.71 | — | — | |
| SCHEMBL13959889 | 0.70 | — | — | |
| SCHEMBL9106682 | 0.70 | — | — | |
| SCHEMBL15172264 | 0.70 | MEN1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3399968-B1 | SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE | CS PHARMATECH LTD (KY) | 2021-10-20 | — | — | EP | disclosed |